Slenyto TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: melatonin
Brand name
(ARTG)
: SLENYTO melatonin 1 mg prolonged release tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
SLENYTO is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, modified release
- Oral
- Pink, round, bi-convex, 3 mm diameter tablets with no imprint.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 tablets (Starter pack) pack
- 30 tablets (Trade pack) pack
- 60 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient melatonin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems